PORTLAND, Ore.--(BUSINESS WIRE)--HemCon Medical Technologies, Inc., announced today that the U.S. Court of Appeals for the Federal Circuit (CAFC) will rehear en banc HemCon's appeal of the patent infringement case brought by Marine Polymer Technologies, Inc. The decision to rehear the appeal en banc means that the appeal will be considered by all eleven active judges on the Federal Circuit and Senior Judge Gajarsa. The CAFC decision to rehear en banc arose following a petition filed by Marine Polymer Technologies, Inc. on October 26, 2011.